Poor performance on quality metrics carried greater risk of in-hospital mortality no matter where patients initially ...

There are hints that the 10-year benefit seen in STICHES, the earlier trial, might be the result of inferior medical therapy.

Revascularization using endovascular techniques is the accepted treatment for many patients with critical limb ischemia. Endovascular technologies continue to evolve and the vascular ...

T he benefits of complete revascularization over culprit-only coronary artery revascularisation were confirmed in older ...

The following is a summary of "Cerebral Hyperperfusion Syndrome After Carotid Revascularization; Predictors and Complications," published in the March 2025 issue of the Annals of Vascular Surgery by ...

Outcomes included all-cause mortality, myocardial infarction (MI), new revascularization with percutaneous coronary ...

Because of TIGERTRIEVER, this study could reexamine how we treat patients.” The TIGERTRIEVER Revascularization Device is the first active thrombectomy device that eliminates the trade-offs of ...

carotid revascularization, limb ischemia, and peripheral revascularization among DM1 and DM2 patients (aged 46 to 75 years) receiving care at outpatient facilities with primary care and/or ...

The incidence of target-lesion revascularization was 6.5, 9.0, and 10.2% at 6, 12 and 24 months, respectively. The MELODIE trial also demonstrated the safety of iliac artery revascularization with ...

carotid revascularization, limb ischemia, and peripheral revascularization among DM1 and DM2 patients (aged 46 to 75 years) receiving care at outpatient facilities with primary care and/or ...